Show simple item record

dc.contributor.author
Honarvar, Hadis
dc.contributor.author
Müller, Cristina
dc.contributor.author
Cohrs, Susan
dc.contributor.author
Haller, Stephanie
dc.contributor.author
Westerlund, Kristina
dc.contributor.author
Eriksson Karlström, Amelie
dc.contributor.author
Meulen, Nicholas P. van der
dc.contributor.author
Schibli, Roger
dc.contributor.author
Tolmachev, Vladimir
dc.date.accessioned
2017-06-12T16:10:07Z
dc.date.available
2017-06-12T16:10:07Z
dc.date.issued
2017-02
dc.identifier.issn
0969-8051
dc.identifier.issn
0883-2897
dc.identifier.issn
1872-9614
dc.identifier.other
10.1016/j.nucmedbio.2016.10.004
dc.identifier.uri
http://hdl.handle.net/20.500.11850/122759
dc.language.iso
en
dc.publisher
Elsevier
dc.subject
44Sc
dc.subject
Affibody molecule
dc.subject
DOTA
dc.subject
HER2
dc.subject
PET imaging
dc.subject
ZHER2:2891
dc.title
Evaluation of the first 44Sc-labeled Affibody molecule for imaging of HER2-expressing tumors
dc.type
Journal Article
ethz.journal.title
Nuclear Medicine and Biology
ethz.journal.volume
45
ethz.journal.abbreviated
Nucl. med. biol.
ethz.pages.start
15
ethz.pages.end
21
ethz.notes
Received 10 September 2016, Revised 15 October 2016, Accepted 16 October 2016, Published online 18 October 2016.
ethz.identifier.wos
ethz.identifier.scopus
ethz.identifier.nebis
000684199
ethz.publication.place
New York, NY
ethz.publication.status
published
ethz.leitzahl
ETH Zürich::00002 - ETH Zürich, direkt::00012 - Lehre und Forschung, direkt::00007 - Departemente, direkt::02020 - Departement Chemie und Angewandte Biowissenschaften / Department of Chemistry and Applied Biosciences::02534 - Institut für Pharmazeutische Wissenschaften / Institute of Pharmaceutical Sciences::03688 - Schibli, Roger
ethz.leitzahl.certified
ETH Zürich::00002 - ETH Zürich, direkt::00012 - Lehre und Forschung, direkt::00007 - Departemente, direkt::02020 - Departement Chemie und Angewandte Biowissenschaften / Department of Chemistry and Applied Biosciences::02534 - Institut für Pharmazeutische Wissenschaften / Institute of Pharmaceutical Sciences::03688 - Schibli, Roger
ethz.date.deposited
2017-06-12T16:15:52Z
ethz.source
ECIT
ethz.identifier.importid
imp593654e0d65a023390
ethz.ecitpid
pub:185087
ethz.eth
yes
ethz.availability
Metadata only
ethz.rosetta.installDate
2017-07-13T02:40:17Z
ethz.rosetta.lastUpdated
2017-07-13T02:40:17Z
ethz.rosetta.versionExported
true
ethz.COinS
ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.atitle=Evaluation%20of%20the%20first%2044Sc-labeled%20Affibody%20molecule%20for%20imaging%20of%20HER2-expressing%20tumors&rft.jtitle=Nuclear%20Medicine%20and%20Biology&rft.date=2017-02&rft.volume=45&rft.spage=15&rft.epage=21&rft.issn=0969-8051&0883-2897&1872-9614&rft.au=Honarvar,%20Hadis&M%C3%BCller,%20Cristina&Cohrs,%20Susan&Haller,%20Stephanie&Westerlund,%20Kristina&rft.genre=article&rft_id=info:doi/10.1016/j.nucmedbio.2016.10.004
 Full text via SFX

Files in this item

FilesSizeFormatOpen in viewer

There are no files associated with this item.

Publication type

Show simple item record